On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
72° Feels Like: 72°
Wind: W 8 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Tonight

Mostly Clear 49°

Tomorrow

Mostly Sunny 73°

Tues Night

Partly Cloudy 53°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Ranbaxy eyes U.S. drug launches with sales exclusivity

MUMBAI (Reuters) - Ranbaxy Laboratories, India's No.1 drugmaker by sales, plans to file three to four generic drug applications every year that can earn it a six-month marketing exclusivity in the United States, the company's chief executive said on Thursday.

The first company that seeks approval from the U.S. Food and Drug Administration for a generic version of a patented medicine gets exclusive rights to sell it for 180 days after patent expiry.

"We have a very ambitious growth plan for our U.S. business," Arun Sawhney, told Reuters in an interview, a month after the company pleaded guilty in a U.S. Justice Department probe related to drug safety.

"We are targeting three to four first-to-file filings every year... We will be strengthening our dermatology business in the U.S. with a good slew of products in the future."

Ranbaxy is controlled by Japan's Daiichi Sankyo Co.

(Reporting by Kaustubh Kulkarni; Editing by Sunil Nair)

Comments